# Vegzelma

NDC: 72606-012
Generic name: bevacizumab-adcd
Labeler / Manufacturer: CELLTRION USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230403

FDA application: BLA761268

## Active ingredients

- BEVACIZUMAB: 400 mg/16mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe